HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A CD44-targeted Cu(ii) delivery 2D nanoplatform for sensitized disulfiram chemotherapy to triple-negative breast cancer.

Abstract
Recent studies have suggested that the anticancer activity of disulfiram (DSF, an FDA-approved alcohol-abuse drug) is Cu-dependent. Low system toxicity and explicit pharmacokinetic characteristics of DSF necessitate safe and effective Cu supplementation in local lesion for further applications. Herein, we presented a new conceptual 'nanosized coordination transport' strategy of Cu(ii) that was realized in porphyrin-based metal-organic frameworks, Sm-TCPP, with strong binding ability to Cu(ii) due to their coordination interactions. Sm-TCPP(Cu) was coated by hyaluronic acid (HA) that termed by Sm-TCPP(Cu)@HA, acting as 'beneficial horse' to target the tumor-localized HA receptor (CD44), thus liberating Cu(ii) ions in cellular overexpressed reductants. The CD44-mediated Cu(ii) accumulation efficiency of Sm-TCPP(Cu)@HA was benchmarked in vitro and vivo against the free TCPP (Cu) via ICP-MS analysis. More importantly, the sensitization effects of Sm-TCPP(Cu)@HA on the anticancer activity of DSF were demonstrated in vivo and in vitro. This study offered a new class of targeted Cu supplements to sensitize DSF for the effective treatment of cancer and established a versatile methodology for constructing a safe and specific delivery of metal ions within living organisms.
AuthorsZhiguo Gao , Yaojia Li , Yu Zhang , Peijing An , Fanghui Chen , Jian Chen , Chaoqun You , Zhifei Wang , Baiwang Sun
JournalNanoscale (Nanoscale) Vol. 12 Issue 15 Pg. 8139-8146 (Apr 21 2020) ISSN: 2040-3372 [Electronic] England
PMID32236229 (Publication Type: Journal Article)
Chemical References
  • Drug Carriers
  • Hyaluronan Receptors
  • Porphyrins
  • tetracarboxyphenylporphine
  • Samarium
  • Copper
  • Hyaluronic Acid
  • Disulfiram
Topics
  • Animals
  • Cell Line, Tumor
  • Copper (administration & dosage, chemistry)
  • Disulfiram (administration & dosage)
  • Drug Carriers
  • Drug Delivery Systems
  • Female
  • Humans
  • Hyaluronan Receptors (metabolism)
  • Hyaluronic Acid (chemistry, metabolism)
  • Mice
  • Nanostructures (administration & dosage, chemistry)
  • Porphyrins (chemistry)
  • Samarium (chemistry)
  • Triple Negative Breast Neoplasms (drug therapy, metabolism, pathology)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: